Bioresonance therapy in complex therapy in pregnant women risk on the development of placental insufficiency

AUTHORS : Zamaleeva R.S. | Galimova I.R. | Nyukhnin M.A.

RELEVANT UNIVERSITIES : Institute of Reflexology of the Federal Scientific Clinical Experimental Center for Traditional Methods of Diagnostics and Treatment of the Ministry of Health RF, Moscow; Moscow State University of Medicine and Dentistry Semashko, Moscow; Russia

YEAR : 2003 | Category : Educational

Placental insufficiency (PN) is one of the most important problems in obstetrics and perinatology. The functional inconsistency of the placenta is the main cause of hypoxia, fetal growth and development retardation, its injuries during childbirth, causes a high incidence of morbidity in newborns, and is the cause of violations of the physical and mental development of the child. In the structure of perinatal losses, the share of PN accounts for 47%, and this figure does not tend to decrease. The incidence of PN in complicated pregnancies is high.

With miscarriage, this pathology is diagnosed from 50 to 77%, with gestosis in 25-75%, in women with antiphospholipid syndrome – in 74%. In pregnant women who have had a viral and bacterial infection, PN is observed in more than 60%, with extragenital pathology – in 25–45%. In pregnancy resulting from in vitro fertilization and embryo transfer, PN develops in 72%. According to the classification of M.V. Fedorova and E.P. Kalashnikova (1986), primary and secondary placental insufficiency are distinguished.